๐Ÿ† 2026 Rankings

The best compounded GLP-1 providers combine all-inclusive pricing, 503B pharmacy partnerships, responsive medical teams, and transparent cancellation policies. We evaluated providers on total monthly cost, pharmacy quality, medical oversight, format options, and patient experience. Here are our rankings.

The compounded GLP-1 market exploded in 2025, with dozens of telehealth platforms launching programs. The result: better prices and more options โ€” but also more noise and more providers cutting corners.

We evaluated compounded GLP-1 providers on five criteria that matter most to patients. Here's how we ranked them.

Our Evaluation Criteria

CriterionWeightWhat We Measured
Total Monthly Cost30%All-in price including consult, medication, shipping, medical oversight
Pharmacy Quality25%503B vs 503A, PCAB accreditation, batch testing practices
Medical Oversight20%Titration guidance, response time, follow-up protocol
Format Options15%Injectable, oral drops, sublingual, lozenges
Patient Experience10%Cancellation ease, shipping speed, platform usability

Top-Rated Compounded GLP-1 Providers

Best Overall: Synergy Rx

Synergy Rx consistently ranks at the top for compounded GLP-1 programs. They offer both compounded semaglutide and tirzepatide in injectable and oral formats, with all-inclusive pricing that covers everything from consultation to ongoing medical oversight.

Why they rank #1: Strong pharmacy partnerships, multiple delivery formats, transparent pricing, and a medical team that proactively manages titration. No hidden fees, no contracts.

Synergy Rx

Top-rated compounded GLP-1 provider

All-inclusive pricingInjectable + oral formats503B pharmacy partnerNo contracts
Check Pricing โ†’

Best Multi-Format: SHED

SHED stands out for offering the widest range of delivery formats โ€” injectable, oral drops, and lozenges. If you're not sure which format you prefer, or if you want to try non-injectable options, SHED gives you the most flexibility without switching providers.

Why they rank high: Format variety means patients can start with injectable (best bioavailability) and switch to drops or lozenges if injection fatigue sets in. All-inclusive pricing across all formats.

SHED

Most delivery format options available

Injectable + drops + lozengesAll-inclusive pricingFormat switching flexibilityNo contracts
Check Pricing โ†’

Best Budget Option: Yucca Health

For patients where cost is the primary concern, Yucca Health offers some of the lowest all-inclusive pricing in the compounded GLP-1 market. Their compounded semaglutide programs start well below $200/month with medical supervision included.

Why they rank high: Consistently among the lowest-priced providers without sacrificing medical oversight. Straightforward program structure.

Yucca Health

Lowest all-inclusive pricing

Budget-friendly compounded semaAll-inclusive pricingMedical oversight included
Check Pricing โ†’

Best for Beginners: MEDVi

MEDVi has built a reputation for guided, beginner-friendly GLP-1 programs. Their onboarding process is thorough, titration guidance is proactive, and their medical team is responsive to questions โ€” all important factors for patients new to GLP-1 treatment.

Why they rank high for beginners: Structured titration timeline, proactive check-ins, both injectable and oral options, responsive support team.

MEDVi

Guided experience for first-time patients

Structured titration supportInjectable + oral optionsProactive medical check-ins
Check Pricing โ†’

Best for Value + Quality: Care Bare Rx

Care Bare Rx hits a sweet spot between budget pricing and quality assurance. Their compounded injectable programs are priced competitively, and they maintain strong pharmacy quality standards.

Care Bare Rx

Strong balance of price and quality

Competitive pricingCompounded injectable focusQuality pharmacy partnerships
Check Pricing โ†’

What to Watch Out For

The "$99/Month" Trap

Several providers advertise eye-catching $99/month pricing. Read the fine print. Common add-ons that inflate the real price: mandatory membership fees ($49-99/month), separate consultation fees ($49-99), shipping charges ($15-30), and lab work fees ($50-200). A "$99" program can easily cost $250-350/month all-in.

Our rankings use total monthly cost โ€” the actual amount you'll pay each month with nothing hidden.

503A vs. 503B Pharmacies

This distinction matters more than most patients realize. 503B outsourcing facilities are FDA-registered, must follow current Good Manufacturing Practices (cGMP), and batch-test every production run. 503A compounding pharmacies are state-regulated, follow USP <797> guidelines, and are not required to batch-test.

Both are legal. Both produce medications used by millions. But 503B facilities provide a higher quality assurance standard. When choosing between providers at similar price points, prefer those partnering with 503B pharmacies.

Regulatory Risk

The compounded GLP-1 market operates under FDA enforcement discretion. Regulatory changes โ€” particularly around shortage list status โ€” can affect which medications providers can offer. The best providers communicate proactively about regulatory changes and have contingency plans.

How We're Different From Other Rankings

Most "best compounded GLP-1" lists are either written by providers ranking themselves (conflict of interest) or by affiliate sites that simply rank by commission payout (highest-paying provider = #1).

We disclose: we earn affiliate commission from featured providers. But our rankings are based on the five criteria above, weighted as shown. Commission rates do not factor into ranking position. A provider paying $350 CPA will rank below a provider paying $175 CPA if the lower-paying provider delivers better value to patients.

Quick Comparison Table

ProviderBest ForFormatsPrice Range
Synergy RxOverall qualityInjectable + oralAll-inclusive
SHEDFormat varietyInjectable + drops + lozengesAll-inclusive
Yucca HealthBudgetInjectableLowest tier
MEDViBeginnersInjectable + oralMid-range
Care Bare RxValue + qualityInjectableCompetitive

Rankings updated March 2026. We re-evaluate quarterly based on pricing changes, pharmacy partnerships, patient feedback, and regulatory developments.